Plasmodium falciparum is a unicellular protozoan parasite of humans, and the deadliest species of Plasmodium that causes malaria in humans. The parasite is transmitted through the bite of a female Anopheles mosquito and causes the disease's most dangerous form, falciparum malaria. It is responsible for around 50% of all malaria cases. P. falciparum is therefore regarded as the deadliest parasite in humans. It is also associated with the development of blood cancer (Burkitt's lymphoma) and is classified as a Group 2A (probable) carcinogen.
The species originated from the malarial parasite Laverania found in gorillas, around 10,000 years ago. Alphonse Laveran was the first to identify the parasite in 1880, and named it Oscillaria malariae. Ronald Ross discovered its transmission by mosquito in 1897. Giovanni Battista Grassi elucidated the complete transmission from a female anopheline mosquito to humans in 1898. In 1897, William H. Welch created the name Plasmodium falciparum, which ICZN formally adopted in 1954. P. falciparum assumes several different forms during its life cycle. The human-infective stage are sporozoites from the salivary gland of a mosquito. The sporozoites grow and multiply in the liver to become merozoites. These merozoites invade the erythrocytes (red blood cells) to form trophozoites, schizonts and gametocytes, during which the symptoms of malaria are produced. In the mosquito, the gametocytes undergo sexual reproduction to a zygote, which turns into ookinete. Ookinete forms oocytes from which sporozoites are formed.
There were 247 million cases of malaria worldwide in 2021, resulting in an estimated 619,000 deaths. Nearly all malarial deaths are caused by P. falciparum, and 95% of such cases occur in Africa. Children under five years of age are most affected, accounting for 80% of the total deaths. In Sub-Saharan Africa, almost 100% of cases were due to P. falciparum, whereas in most other malarial countries, other, less virulent plasmodial species predominate.
Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.
Explore les cibles de médicaments enzymatiques, les inhibiteurs de la tyrosine kinase, le contrôle du tonus vasculaire et les interventions du cycle de vie viral.
Explore les systèmes Biologie, les voies métaboliques, les modèles à l'échelle du génome et les outils bio-informatiques pour la biochimie prédictive en bioproduction.
Antimalarial medications or simply antimalarials are a type of antiparasitic chemical agent, often naturally derived, that can be used to treat or to prevent malaria, in the latter case, most often aiming at two susceptible target groups, young children and pregnant women. As of 2018, modern treatments, including for severe malaria, continued to depend on therapies deriving historically from quinine and artesunate, both parenteral (injectable) drugs, expanding from there into the many classes of available modern drugs.
Plasmodium vivax est la cause la plus fréquente de la fièvre tierce bénigne, l'une des formes du paludisme encore appelé malaria. Cette maladie est moins virulente que le P. falciparum, et souvent considérée comme bénigne. Elle est néanmoins débilitante et parfois mortelle, et économiquement coûteuse (coût estimé entre 1,4 et 4 milliards de dollars américains par an) dans de nombreux pays tropicaux et tempérés hors d'Afrique.
Ronald Ross ( à Almora, Inde - le à Londres) est un médecin bactériologiste et entomologiste britannique de l’Armée des Indes britanniques qui parvient à montrer, le , que la transmission du paludisme des oiseaux se fait par un moustique. En 1902, il reçoit le prix Nobel de physiologie ou médecine pour ses travaux sur le paludisme. Ronald Ross fait ses études à Londres. Il entre dans les services médicaux militaires anglo-indiens en 1881 et 11 ans plus tard commence ses recherches sur la transmission du paludisme et la lutte contre cette maladie.
The Eukaryotic Promoter Database (EPD), available online at https://epd.epfl.ch, provides accurate transcription start site (TSS) information for promoters of 15 model organisms plus corresponding functional genomics data that can be viewed in a genome bro ...
2020
,
Infectious diseases continue to pose a substantial burden on global populations, requiring innovative broad-spectrum prophylactic and treatment alternatives. Here, we have designed modular synthetic polymer nanopartides that mimic functional components of ...
AMER CHEMICAL SOC2022
, , , ,
The discovery of a drug requires over a decade of intensive research and financial investments – and still has a high risk of failure. To reduce this burden, we developed the NICEdrug.ch resource, which incorporates 250,000 bioactive molecules, and studied ...